Skip to main content
Log in

Complete cytogenetic remission in a patient with FIP1L1-PDGFRA fusion negative chronic eosinophilic leukemia associated with atypical thrombotic events

  • Case report
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

We present a rare case of a patient with chronic eosinophilic leukemia, who did not develope the well known organ involvements of the heart, lungs, the skin or nervous system, but who suffered form atypical thrombotic complications including a life threatening sinovenous thrombosis. His disease showed a rapid response to a very low dose of imatinib an the complete remission of a complex cytogenetic abnormality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Hellmich B, Holl-Ulrich K Gross W. Hypereosinophiles Syndrom: Aktueller Stand der Diagnostik und Therapie. Dtsch Med Wochenschr, 132: 1892–1896, 2007

    Article  PubMed  CAS  Google Scholar 

  • Roufossue F, Goldman M, Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Diseases, 2: 37, 2007 (DOI: 10.1186/1750-1172-2-37)

    Article  Google Scholar 

  • Roufosse F, Cogan A, Goldman M. Recent advances in the pathogenesis and management of hypereosinopholic syndromes. Allergy, 59: 673–689, 2004

    Article  PubMed  CAS  Google Scholar 

  • Cools J, DeAngelo D, Gotlib J, et al. A tyrosin kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med, 348: 1201–1214, 2003

    Article  PubMed  CAS  Google Scholar 

  • Cross NCP, Reiter A. Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia, 16: 1207–1212, 2002

    Article  PubMed  CAS  Google Scholar 

  • Narayan S, Ezughah F, Standen G, et al. Idiopathic hypereosinophilic syndrome associated with cutaneous infarction and deep venous thrombosis. Br J Dermatol, 148: 817–820, 2003

    Article  PubMed  CAS  Google Scholar 

  • Schulman H, Hertzog L, Zirkin H, Hertzanu Y. Cerebral sinovenous thrombosis in the idiopathic hypereosinophilic syndrome in childhood. Pediatr Radiol, 29: 595–597, 1999

    Article  PubMed  CAS  Google Scholar 

  • Cortes J, Ault P, Koller Ch, et al. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood, 101: 4714–4716, 2003

    Article  PubMed  CAS  Google Scholar 

  • Onitilo A, Kio E, Singh A, Lazarchick J. Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction. Leuk Lymphoma, 46(11): 1667–1670, 2005

    Article  PubMed  Google Scholar 

  • Yamada O, Kitahara K, Imamura K, Ozasa H, Okada M, Mizoguchi H. Clinical and cytogenetic remission induced by interferon-alpha in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation. Am J Haematol, 58(2): 137–141, 1998

    Article  CAS  Google Scholar 

  • Rothenberg M, Gleich G, Roufosse F, Rossenwasser L, Weller P. Steroid sparing effect of anti-IL5 antibody (mepolizumab) therapy in patients with HES: a multicenter, randomized, double-blind, placebo-controlled trial. Blood, 108: 373, 2006

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Zabernigg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zabernigg, A., Erdel, M., Schranzhofer, R. et al. Complete cytogenetic remission in a patient with FIP1L1-PDGFRA fusion negative chronic eosinophilic leukemia associated with atypical thrombotic events. memo 1, 39–41 (2008). https://doi.org/10.1007/s12254-008-0010-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-008-0010-9

Keywords

Navigation